Page 50 - Covid Special Issue

NISCAIR published a special edition of ‘Science Diplomacy’ on
COVID-19
National Institute of Science Communication and Information Resources (CSIR-NISCAIR) published a special edition of ‘Science Diplomacy’ on COVID-19 in India in Apr-Jun 2020, Vol. 3(4). ‘Science Diplomacy’ is among the first endeavours to bring highlights of Indian scientific achievements in foreign languages. It helps in identifying priority areas for collaboration and involvement of stakeholders in policy-making and strategic engagements, including scientists, academicians, senior diplomats, science counsellors and experts.
In the special edition, perspectives from S4D4C have been covered along with the correspondence with scientists across the globe sharing their stories on COVID-19 global reverberations. S4D4C – the full project title ‘Using Science for/in Diplomacy for Addressing Global Challenges’ – is a European project, co-funded by the European Commission under the Horizon 2020 programme.
Website link:
https://www.niscair.res.in/includes/images/sciencediplomacy/Science-Diplomacy-April-June-2020.pdf
CSIR published compendium on technologies
for COVID-19 mitigation
CSIR published a compendium on technologies for COVID-19 mitigation to provide an insight into the technologies developed by its organisations as well as to spur more innovations. With an ‘Aatmanirbhar Bharat’ high on its agenda, CSIR is eager to partner with more industries to take these technologies to the users although around 60% of technologies listed in this compendium have already been transferred to industry partners.
Website link:
https://www.csir.res.in/sites/default/files/Final%20Covid-19%20 Compendium-Jan2021_0.pdf
Drug Discovery Hackathon 2020 launched for drug discovery against
COVID-19
Drug Discovery Hackathon 2020 (DDH2020) platform welcomed all those who wished to join the open-source drug discovery Hackathon against COVID-19. DDH2020 was a joint initiative of All India Council for Technical Education (AICTE) and Council of Scientific and Industrial Research (CSIR) and supported by Office of the Principal Scientific Adviser (PSA), Government of India, National Informatics Centre (NIC) and MyGov India.
The vision and mission of DDH2020 was to established ‘Open innovation Model’ for in silico drug discovery against COVID-19 virus and to cover the various processes in drug discovery, including but not limited to, in silico screening of molecules, lead optimization and identification of drug-able non-toxic targets. The targets/tools/lead molecules identified through the process of DDH2020 will be further taken forward for synthesis followed by subsequent steps in routine drug discovery programme.
46